Victrex plc (LON:VCT) had its target price hoisted by equities research analysts at Jefferies Group LLC from GBX 2,050 ($26.48) to GBX 2,268 ($29.29) in a report released on Tuesday. The brokerage presently has a “hold” rating on the stock. Jefferies Group LLC’s price target suggests a potential downside of 1.95% from the company’s current price.

VCT has been the topic of several other research reports. UBS AG started coverage on Victrex plc in a report on Monday, August 21st. They set a “neutral” rating and a GBX 2,050 ($26.48) price target on the stock. Liberum Capital restated a “buy” rating and set a GBX 2,240 ($28.93) price target on shares of Victrex plc in a report on Monday. Berenberg Bank increased their price target on Victrex plc from GBX 1,800 ($23.25) to GBX 2,000 ($25.83) and gave the company a “hold” rating in a report on Tuesday, May 16th. Deutsche Bank AG restated a “hold” rating on shares of Victrex plc in a report on Thursday, August 24th. Finally, N+1 Singer restated a “hold” rating and set a GBX 2,000 ($25.83) price target on shares of Victrex plc in a report on Monday, May 15th. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and three have issued a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of GBX 2,117.33 ($27.35).

Victrex plc (LON:VCT) opened at 2317.00 on Tuesday. The company has a 50 day moving average of GBX 2,027.00 and a 200 day moving average of GBX 1,951.07. Victrex plc has a 52 week low of GBX 1,473.00 and a 52 week high of GBX 2,342.00. The stock’s market capitalization is GBX 1.98 billion.

ILLEGAL ACTIVITY WARNING: This piece was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece on another website, it was illegally stolen and republished in violation of United States and international trademark & copyright laws. The legal version of this piece can be viewed at

About Victrex plc

Victrex plc is a United Kingdom-based holding company. The Company is engaged in the manufacture and sale of various polymers. The Company’s operating segments include Industrial (Victrex Polymer Solutions) and Medical (Invibio Biomaterial Solutions). The Victrex Polymer Solutions segment focuses on automotive, aerospace, electronics and energy markets.

Analyst Recommendations for Victrex plc (LON:VCT)

Receive News & Stock Ratings for Victrex plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex plc and related stocks with our FREE daily email newsletter.